MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients

• Alfons Navarro ,

  * E-mail: anavarroponz@ub.edu

  Affiliation Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain

  ⨯
• Carmen Muñoz,

  Affiliation Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain

  ⨯
• Anna Gaya,

  Affiliation Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain

  ⨯
• Marina Díaz-Beyá,

  Affiliations Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain, Josep Carreras Leukaemia Research Institute, Barcelona, Spain

  ⨯
• Bernat Gel,

  Affiliation Hereditary Cancer Program, Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Spain

  ⨯
• Rut Tejero,

  Affiliation Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain

  ⨯
• Tania Díaz,

  Affiliation Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain

  ⨯
• Antonio Martinez,

  Affiliation Department of Pathology, Hospital Clínic, Barcelona, Spain

  ⨯
• Mariano Monzó

  Affiliation Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain

  ⨯